As you may imagine, planning for FOCIS 2013 in Boston is well underway. As chair of the Scientific Program Committee, I know you will find this year's program to be exciting and progressive with sessions on cutting edge technologies, monitoring and treating diseases.
I am sure you, like me, have seen many conference opportunities presented for 2013 and you may ask why FOCIS? For me this is an easy choice. FOCIS provides the ability for you to join with some on the brightest people in immunology spanning very basic research to translational and clinical work. FOCIS exposes you to the possibilities of new therapies and discoveries from other fields that you can utilize immediately in your own work.
For trainees FOCIS is an opportunity to move forward on the path to thought leadership. Submit an abstract and attend the conference to gain access to leaders across the field for collaboration and networking. The knowledge gained in just three days at FOCIS will open your mind to new ways to apply work in other fields to your disease-specific area.
For leaders in the field of immunology this conference provides networking opportunities and access to relationships between fields that help build better and faster pathways to progress. It's thinking out of the box that brings forward new discoveries and techniques and a way to gain knowledge by looking at problems through a different lens.
Regardless of your goals, FOCIS 2013 can move you up the ladder to success. Start by becoming a member, submitting an abstract, or simply joining your colleagues at FOCIS 2013, June 27-30 in Boston, Massachusetts. See you there!
Steven Ziegler, PhD
"FOCIS brings together the brightest minds across the globe to tackle major public health problems and is doing it via a translational approach to immunology. You won't find anywhere else a solution to those problems as you would find it in the context of the FOCIS conference" – Frank Nestle, MD, Kings College London
Plenary Session Topics
Thematic Session Topics
Join our member societies in their collaborative forum as they present on disease-area specific research at FOCIS 2013.
|Abstract submission, meeting registration, and housing open||Monday, December 3, 2012|
|Abstract submission deadline||Friday, January 25, 2013|
|Meeting registration deadline for poster presenters||Thursday, March 28, 2013|
|Late-breaking abstract submission deadline||Tuesday, April 2, 2013|
|Headquarter hotel registration discount deadline||Friday, May 3, 2013|
|FOCIS 2013||Thursday, June 27 through Sunday, June 30, 2013|
FOCIS 2013 is the meeting in translational immunology, and you have the opportunity to gain visibility and interact with leading clinicians and researchers throughout the immunology community! Explore the 2013 Support Opportunities brochure to learn about all of the options. Make sure to reserve your support package and exhibit space now!
The newest installation of the members-only publication, Translational Immunology Update was released on December 17. This publication is available to FOCIS members only. The titles from this issue include:
Clinical Immunology publishes original research on the molecular and cellular bases of immunological disease. The journal also features reviews of timely topics in basic immunology, case reports and letters to the editor.
Courtesy of FOCIS' partnership with Elsevier and Clinical Immunology, all FOCIS members receive free access to the online journal via the FOCIS Members Only Site and are guaranteed to have their papers sent out for review when submitted to the journal. Clinical Immunology also provides author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on author services and the guide for authors.
More than 1,000 immunology professionals are defining the art of interdisciplinary collaboration through their membership in FOCIS. Please continue this momentum and join or renew today!FOCIS members receive:
Looking to advance your career? Get an immunology edge by participating in FOCISed programs!
Advanced Course in Basic & Clinical Immunology
Don’t miss your chance to register for the 2013 Advanced Course in Basic & Clinical Immunology, February 24-28 at the FireSky Resort & Spa in Scottsdale, Arizona. The course boasts world-renowned faculty, the latest and hottest immunology science, all in a sunny and beautiful location. Check out pictures from last year’s course.
Need more reasons to attend?
Basic Immunology in Medicine
This course was launched in 2002 because of the realization that the rapid pace of research is leading to fundamental advances in the understanding of immune responses and their abnormalities. Staying abreast of these advances is essential for practitioners of medicine and for researchers in academia and industry. As new immunotherapeutic strategies are being developed and adopted, it is becoming important to understand the rationale behind these therapies, and this also requires an appreciation of the fundamentals of immunology. This brief course is designed to provide a sophisticated review of selected basic principles, and update on new advances, especially those that are most relevant to human disease.
The Interventional Immunology course provides education on the many new therapies that are currently available or in development which are based on targets unfamiliar to many practicing physicians. There is potentially great value for, but lack of, cross-disciplinary reviews of these types of therapies.
This course seeks to review the scientific basis for choice of immunologically related therapeutic targets in various diseases, including organ specific and systemic autoimmunity, allergy, transplant rejection, cancer, and HIV. The goal is to help understand the rationale and mechanism underlying the major pharmacologic approaches for interventional immunology in current practice and review the track record of the different therapeutic approaches in different specialties.
Clinical Trials in Immunologic Disease
This is a basic course in clinic trial methodology, particularly as it relates to immunologic disease. It will review the key elements of clinical trials, including types of trials, designing feasible trials, statistical issues, and surrogate markers that might be used. It will discuss strategies for entering into the funding stream. A practicum will be offered to participants using a model scenario in order to work through the issues one faces in developing a clinical trial.
We get it. And it doesn't mean that your professional development has to suffer. FOCIS is proud to bring you FOCISed Online. FOCIS' lauded and internationally recognized collection of educational courses are now available online and FREE to FOCIS members.
Check out a sneak preview of the online content FOCIS has to offer:
Advanced Course in Basic
Intentional Immunology Course
Clinical Trials in Immunologic
Help your sales force talk the talk and your research team walk the walk. Bring FOCIS key opinion leaders directly to your company's site to educate your employees on the fundamentals and application of immunology. Basic Immunology in Medicine To Go is an up-to-date, clinically relevant overview of how the immune system functions and malfunctions, presented in a manner that is accessible and of interest to individuals with various levels of scientific knowledge.
Choose the one or two-day option:
Day one: Basic immunology education
Day two (optional): Targeted education directly applicable to your company's interest area
What industry attendees are saying about the Basic Immunology in Medicine To Go Course...
"I enjoyed the class and was able to take away key concepts in immunology. I feel more comfortable being able to have a conversation with someone more knowledgeable in this subject area than I did before this class."
"As a result of this course I have improved my ability to understand the basic science underlying immunotherapy drug development."
"I recommend organizing this course and similar ones at regular intervals."
Education and insight from leading experts, a unique opportunity not to be missed.
[CLOSING DATE EXTENDED TO JANUARY 31, 2013]
As you are aware, FOCIS has recently embarked on a new initiative offering medical academics the chance to discover more about the drug development process and how to get the most out of their research: the Entrepreneurs in Clinical Academia (ECA) course. This once in a lifetime opportunity aims to bring academic researchers together with leading experts to encourage mutual understanding and co-operation between academia and industry. The faculty of this unique course will draw on expertise across a range of disciplines:
More information on each of the faculty members can be found on the ECA website, where you can also read their assertions for involvement in such a unique initiative.
The course is solely supported by Celgene, a biopharmaceutical company closely aligned with the goals of FOCIS to improve translation of scientific ideas and observations into therapeutics and benefits for patients with immune and inflammatory diseases. Furthermore, it will be delivered by one the world's leading graduate business schools and a pioneer of international business education, INSEAD in Fontainebleau, France.
Running from September 23–27, 2013, the course tuition fees, on site accommodation and transport will be covered by FOCIS thanks to an educational grant from Celgene. All sessions will be held in English and only European-based applicants will be considered. The application process has recently been updated to include a saving and editing function, allowing you to perfect your application before submission and maximize your chances of being accepted for this unique opportunity! Places are limited, so if this course is of interest to you or if you know of a colleague who would be a suitable candidate, please visit the website and start the application process today!
Mission & Goals: The Society for Investigative Dermatology (SID) mission is to advance and promote the sciences relevant to skin health and disease through education, advocacy and scholarly exchange of scientific information. Working under this mission, the SID is committed to fostering scientific careers for young researchers, increasing public and government awareness about the need to support skin research, working with industry in the development of new technologies and cooperative ventures, and encouraging scientific collaborations among researchers worldwide.
Membership: SID membership consists of approximately 2,200 members worldwide representing academia, government, private practice and industry, including MD, MD/PhD, or PhDs in training. More information about the SID, its educational programs, and membership is available on the SID website.
Annual Meeting: SID has held an Annual Meeting every year but one since its founding in 1937. In addition, every five years, the Society holds a Tri-Society meeting with the European Society for Dermatologic Research and the Japanese Society for Investigative Dermatology. The audience of this meeting represents the global skin research community with representatives from over 30 countries attending each year. Its annual meeting now averages 1,500 attendees and more than 900 abstract submissions each year. Attendee representation usually includes more than 500 residents and more than 650 academic faculty members.
International Investigative Dermatology (IID) 2013 Meeting.
May 8-11, 2013
In Memoriam: George Eisenbarth
FOCIS mourns the loss of Dr. George S. Eisenbarth, MD, PhD, who passed away on November 13 after a struggle with pancreatic cancer. A pioneer in the field of diabetes, George had an innovative and collaborative spirit. Among his many scientific contributions to the diabetes and immunology communities, he was instrumental in the vision and creation of the FOCIS Board of Directors and served as its Membership Chair for eight plus years. During this time he formalized the application and induction process for Member Societies to join the Federation to further the FOCIS vision of improving human health by fostering interdisciplinary approaches to both understand and treat immune-based diseases. George was a kind soul whose contributions, both scientifically and personally, will be greatly missed.
Dr. Anthony Shum Awarded $80,000 for Interstitial Lung Disease Research
Anthony Shum, MD, Assistant Professor in the Division of Pulmonary and Critical Care at the University of California, San Francisco, is the recipient of the American Thoracic Society Foundation/Pulmonary Fibrosis Foundation Research Grant. The award will provide funding for the project "Defining the Molecular Basis of Interstitial Lung Disease in Rheumatoid Arthritis." The grant provides $80,000 in funding over two years. The grant is supported through a partnership between the ATS Foundation and Pulmonary Fibrosis Foundation. Dr. Shum will take advantage of an exciting new technology called exome sequencing to identify the genes that trigger ILD in rheumatoid arthritis patients. Ultimately, Dr. Shum hopes that his work will improve understanding of how these genes cause disease, which will in turn lead to development of new diagnostic and treatment strategies for pulmonary fibrosis in RA.
The FOCIS Foundation was launched in 2012 as a tool for building on the success of FOCIS educational programs, collaborations and annual meetings. While the foundation’s highly publicized C. Garrison Fathman Fellows Fund has raised more than $10,000 for trainee awards in its first year, there are several other areas that the foundation plans to support in the future. As a donor, you may choose the area that you would like to support:
FOCISed: Donate directly to the development of FOCIS' leading educational programs. Funds will assist in the continuation of established courses and lead to the development of new courses that keep up with the speed of medicine.
Annual Meeting: The apex of the year's activities, the FOCIS Annual Meeting calls together an impressive collection of the world's leading clinicians and scientists. FOCIS' unique approach of interdisciplinary immunology leads to the most novel discussions and scientific collaborations.
Research: FOCIS is a forum for cutting edge research groups that in the past have identified genetic commonalities between multiple diseases to help identify and treat chronic and life threatening conditions. These collaborations have evolved to lead the way in standardization in medicine, allowing for widespread data sharing and dramatically increasing the speed of finding treatments and cures.
Fellows Fund: The C. Garrison Fathman Fellows Fund enables trainees and fellows to attend the FOCIS Annual Meeting, educational courses and participate in exchange programs. FOCIS is known world-wide for outstanding immunology education. Help the future of medicine get on the right track to identify new treatments for immune-based diseases.
For a complete list of donation options or to make a general donation, please visit the FOCIS Donations Portal.
What is the coolest way that you facilitate interdisciplinary research?
Marincola: There are several ways to explore this question; how to integrate basic with clinical research, genetic studies with investigations assessing environmental and other acquired factors, looking at immunology as an overreaching discipline covering disease processes traditionally studied as independent entities. There are several ways to integrate these overlapping entities through 1) interdisciplinary conferences such as the FOCIS meeting; such meetings should aim at presenting the top achievement of each discipline equally represented to provide participants with information potentially relevant to their work but unlikely to be presented at specialty meetings. Moreover, these broad-based conferences represent an excellent venue for young investigators to interact; 2) identify general immunological questions that apply to various diseases and facilitate exchanges focused on the solution of that particular problem for example by designing mechanistic clinical trials aimed at obtaining relevant human samples, defining standards for their storage and utilization, streamlining analytical tools and providing the information to researchers with various skills for their interpretation. The key to success is the quality and rigor of the study design and this can be improved by a broad participation of researchers from all the areas of expertise from the onset.
Why do you dig immunology?
Marincola: Immunology is important; several diseases are affected in one way or another by immune responses whether they are normal, deficient or overactive. I feel we need to understand it better for improved treatments, particularly for diseases not intuitively related to it but for which the role of immune modulation is becoming increasingly appreciated.
What is your vision for the future of immunology?
Marincola: The relevance of immunology to several aspects of human disease is becoming progressively recognized; good examples are cardiovascular diseases and cancer; however, there is still skepticism and resistance from the medical community to accept novel therapies requiring immune modulation because of lack of familiarity with immunologic concepts; these effort could go along with education of the community at large to understand and appreciate the role that immunology can play for the prevention and treatment of disease. In the future clinical immunology should take a more significant role across disciplines. Another important aim is the effective exchange of knowledge between basic and clinical scientists to focus experimental models on answering questions of true clinical relevance, present basic scientists with clinical results that my confute or corroborate hypotheses based on experimentation and in summary, increase the efficiency of exchanges for the benefit of patients. Finally, it will be important to encourage the study of interactions between the immune and other physiological systems such as the nervous and the endocrine system, understanding circadian rhythms, the effect of the environment, the microbiome etc. All these are emerging concepts that are just reaching the surface and will keep us busy for the time being.
Remember to visit the FOCIS Grants/Awards site regularly to view new grant opportunities in the field of clinical immunology and related disciplines. Grants are currently listed from the NIAID, NIDDK, NIAMS, NIH Roadmap and many more.
From academia to government to industry; below are the openings available in the immunology job market! Click on each job posting to find out more details.
Oklahoma Medical Research Foundation (OMRF), Oklahoma City, OK
Assistant or Associate Member - Arthritis & Clinical Immunology
Oklahoma Medical Research Foundation (OMRF), Oklahoma City, OK
Associate Member – MS Center of Excellence in the Arthritis and Clinical Immunology Research Program
Mayo Clinic, Rochester, MN
Director, Cellular and Molecular Immunology Laboratory
Relevant meetings and educational programs from our Member Societies and partners in immunology.
Keystone Symposia: Emerging Topics in Immune System Plasticity
January 15–20, 2013
Santa Fe, New Mexico
Keystone Symposia: Malaria
January 20–25, 2013
New Orleans, Louisiana
Keystone Symposia: Metabolic Control of Inflammation and Immunity
January 21–26, 2013
Keystone Symposia: Antibodies as Drugs joint with Cancer Immunology and Immunotherapy
January 27–February 1, 2013
Vancouver, BC, Canada
Keystone Symposia: Diabetes – New Insights into Mechanisms of Disease and its Treatment
January 27–February 1, 2013
Keystone Symposia: The Gut Microbiome: The Effector/Regulatory Immune Network
February 10–15, 2013
Taos, New Mexico
Keystone Symposia: B Cell Development and Function joint with HIV Vaccines
February 10–15, 2013
Keystone Symposia: Autophagy, Inflammation and Immunity
February 17–22, 2013
Montreal, QC, Canada
Keystone Symposia: Myeloid Cells: Regulation and Inflammation
February 19–24, 2013
FOCIS Advanced Course in Basic & Clinical Immunology
February 24-28, 2013
Keystone Symposia: Understanding Dendritic Cell Biology to Advance Disease Therapies
March 3–8, 2013
Keystone Symposia: Host Response in Tuberculosis: Understanding the Enemy
March 13–18, 2013
Whistler, British Columbia
Keystone Symposia: Immune Activation in HIV Infection: Basic Mechanisms and Clinical Implications
April 3–8, 2013
Keystone Symposia: Immunopathology of Type 1 Diabetes joint with Advances in the Knowledge and Treatment of Autoimmunity
April 4–9, 2013
Whistler, BC, Canada
Keystone Symposia: Positive Strand RNA Viruses
April 28–May 3, 2013
Keystone Symposia: The Innate Immune Response in the Pathogenesis of Infectious Disease
May 10–15, 2013
Ouro Preto, Brazil
18th Nantes/Actualités/Transplantation (NAT) Conference
June 24–25, 2013
FOCIS Basic Immunology in Medicine: Update 2013
June 26, 2013
June 27-30, 2013
FOCIS Interventional Immunology
June 27, 2013
FOCIS Clinical Trials for Immunologic Disease
June 30, 2013
EAACI & WAO Annual Meeting
June 22-26, 2013
Entrepeneurs in Clinical Academia
September 23–27, 2013
Immunological Mechanisms of Vaccination
December 13–18, 2012
Ottawa, Ontario, Canada
FOCIS is a federation of societies that unite under the common mission to improve human health through immunology.
Academy of Clinical Laboratory Physicians and Scientists • American Academy of Allergy, Asthma Immunology
American College of Rheumatology • American Rhinological Society • American Society for Blood and Marrow Transplantation
American Society for Histocompatibility and Immunogenetics • American Society of Nephrology • American Society of Transplantation
American Uveitis Society • Americas Committee for Treatment and Research in Multiple Sclerosis
Association for Cancer Immunotherapy • Association of Medical Laboratory Immunologists
Australasian Society of Clinical Immunology and Allergy • British Society for Immunology
Cancer Research Institue • Center for International Blood and Marrow Transplant Research
Clinical Immunology Chapter of the Sociedad Mexicana de Immunología • Clinical Immunology Society
Commonwealth of Independent States Society of Allergology and Clinical Immunology
Croatian Society of Allergology and Clinical Immunology • Crohn's and Colitis Foundation of America
Egyptian Society of Pediatric Allergy and Immunology
European Academy of Allergy & Clinical Immunology • European Society for Immunodeficiencies
European Society for Organ Transplantation • Georgian Association of Allegology and Clinical Immunology
German Society of Immunology • Immune Tolerance Network • Immunology of Diabetes Society
International Complement Society • International Cytokine Society
International Life Sciences Institute/Health and Environmental Sciences Institute
International Society for Interferon and Cytokine Research
International Society for NeuroImmunoModulation • International Society of Neuroimmunology
Israel Association of Allergy and Clinical Immunology • Italian Society of Allergology and Clinical Immunology
Japanese Society for Immunology • Lithuanian Society of Pulmonology and Allergy
National Institute of Allergy and Infectious Diseases • Pan American Group for Immunodefiency
Section of Clinical Immunology and Allergy of the Royal Society of Medicine
Section for Clinical Immunology of the Swedish Society of Medicine • Society of Innate Immunity • Society for Immunotheraphy of Cancer
Society for Investigative Dermatology • Society for Mucosal Immunology • The Transplantation Society
Ukrainian Society of Immunology and Allergy • Uveitis Association of Mexico • World Allergy Organization